These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 32865893)

  • 1. Mushrooms Bioactive as Prebiotics to Modulate Gut Microbiota in Relationships with Causes and Prevention of Liver Diseases (Review).
    Nguepi TIS; Song H
    Int J Med Mushrooms; 2020; 22(6):509-519. PubMed ID: 32865893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Critical Review on Health Promoting Benefits of Edible Mushrooms through Gut Microbiota.
    Jayachandran M; Xiao J; Xu B
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Review on Linking the Medicinal Functions of Mushroom Prebiotics with Gut Microbiota.
    Liu X; Yu Z; Jia W; Wu Y; Wu D; Zhang H; Liu Z; Yang Y; Zhang J; Liu Y; Tang C; Wang W; Zhu L
    Int J Med Mushrooms; 2020; 22(10):943-951. PubMed ID: 33426824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota in liver disease.
    Haque TR; Barritt AS
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):133-42. PubMed ID: 27048904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Mushroom Polysaccharides for the Development of Novel Prebiotics: A Review.
    Fernandes A; Nair A; Kulkarni N; Todewale N; Jobby R
    Int J Med Mushrooms; 2023; 25(2):1-10. PubMed ID: 36749052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the gut microbiota in the pathology and prevention of liver disease.
    Altamirano-Barrera A; Uribe M; Chávez-Tapia NC; Nuño-Lámbarri N
    J Nutr Biochem; 2018 Oct; 60():1-8. PubMed ID: 29653359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of functional food components on gut health.
    Wan MLY; Ling KH; El-Nezami H; Wang MF
    Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
    Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiosis and liver diseases (Review).
    Nishikawa H; Fukunishi S; Asai A; Yokohama K; Ohama H; Nishiguchi S; Higuchi K
    Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34328191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Prebiotics on Enteric Diseases and Oxidative Stress.
    Gao J; Azad MAK; Han H; Wan D; Li T
    Curr Pharm Des; 2020; 26(22):2630-2641. PubMed ID: 32066357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of gut microbiota in chronic liver diseases, and treatment possibilities].
    Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G
    Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mushroom as Prebiotics: a Sustainable Approach for Healthcare.
    Kulshreshtha S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):699-712. PubMed ID: 37776487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mutual interplay of gut microbiota, diet and human disease.
    Illiano P; Brambilla R; Parolini C
    FEBS J; 2020 Mar; 287(5):833-855. PubMed ID: 31955527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gut-liver axis: How intestinal bacteria affect the liver].
    Konturek PC; Harsch IA; Konturek K; Schink M; Zopf Y
    MMW Fortschr Med; 2018 Nov; 160(Suppl 5):11-15. PubMed ID: 30367438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics and liver disease.
    Sharma V; Garg S; Aggarwal S
    Perm J; 2013; 17(4):62-7. PubMed ID: 24361022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation effects of indigestible dietary polysaccharides on intestinal microflora: An overview.
    Ge Y; Ahmed S; Yao W; You L; Zheng J; Hileuskaya K
    J Food Biochem; 2021 Jan; 45(1):e13564. PubMed ID: 33219555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulatory effects of polysaccharides from plants, marine algae and edible mushrooms on gut microbiota and related health benefits: A review.
    Zhang H; Jiang F; Zhang J; Wang W; Li L; Yan J
    Int J Biol Macromol; 2022 Apr; 204():169-192. PubMed ID: 35122806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the gut microbiota in NAFLD.
    Leung C; Rivera L; Furness JB; Angus PW
    Nat Rev Gastroenterol Hepatol; 2016 Jul; 13(7):412-25. PubMed ID: 27273168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.